HEADER HYDROLASE 08-FEB-14 4CPT
TITLE MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS
TITLE 2 ENCOMPASSING A TERTIARY ALCOHOL
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PROTEASE;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: PR, RETROPEPSIN;
COMPND 5 EC: 3.4.23.16;
COMPND 6 ENGINEERED: YES;
COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS;
SOURCE 3 ORGANISM_TAXID: 12721;
SOURCE 4 STRAIN: 99HHP1 (D10);
SOURCE 5 VARIANT: Z2/CDC-Z34 ISOLATE;
SOURCE 6 ATCC: 11676;
SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693;
SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21;
SOURCE 10 EXPRESSION_SYSTEM_VARIANT: AI;
SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PEXP5
KEYWDS HYDROLASE, HIV-1 PROTEASE, INHIBITOR, RATIONAL DRUG DESIGN, ENZYME
EXPDTA X-RAY DIFFRACTION
AUTHOR M.DEROSA,J.UNGE,H.V.MOTWANI,A.ROSENQUIST,L.VRANG,H.WALLBERG,M.LARHED
REVDAT 3 01-MAY-24 4CPT 1 REMARK SHEET
REVDAT 2 17-JAN-18 4CPT 1 REMARK
REVDAT 1 17-DEC-14 4CPT 0
JRNL AUTH M.DE ROSA,J.UNGE,H.V.MOTWANI,A.ROSENQUIST,L.VRANG,
JRNL AUTH 2 H.WALLBERG,M.LARHED
JRNL TITL SYNTHESIS OF P1'-FUNCTIONALIZED MACROCYCLIC TRANSITION-STATE
JRNL TITL 2 MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY
JRNL TITL 3 ALCOHOL.
JRNL REF J.MED.CHEM. V. 57 6444 2014
JRNL REFN ISSN 0022-2623
JRNL PMID 25054811
JRNL DOI 10.1021/JM500434Q
REMARK 2
REMARK 2 RESOLUTION. 1.70 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.8.0049
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.51
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7
REMARK 3 NUMBER OF REFLECTIONS : 24849
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.175
REMARK 3 R VALUE (WORKING SET) : 0.174
REMARK 3 FREE R VALUE : 0.203
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 1336
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1780
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.63
REMARK 3 BIN R VALUE (WORKING SET) : 0.2220
REMARK 3 BIN FREE R VALUE SET COUNT : 115
REMARK 3 BIN FREE R VALUE : 0.2280
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1512
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 56
REMARK 3 SOLVENT ATOMS : 270
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.05
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.36000
REMARK 3 B22 (A**2) : -0.35000
REMARK 3 B33 (A**2) : 0.00000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.099
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.097
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.062
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.872
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1619 ; 0.006 ; 0.020
REMARK 3 BOND LENGTHS OTHERS (A): 1641 ; 0.000 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2207 ; 0.950 ; 2.040
REMARK 3 BOND ANGLES OTHERS (DEGREES): 3783 ; 0.640 ; 3.012
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 205 ; 7.020 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 55 ;40.874 ;24.909
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 283 ;13.259 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;17.416 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 258 ; 0.060 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1786 ; 0.016 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 338 ; 0.008 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 804 ; 1.324 ; 0.919
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 805 ; 1.323 ; 0.920
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1002 ; 1.926 ; 1.370
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 815 ; 3.281 ; 1.289
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY
REMARK 4
REMARK 4 4CPT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-FEB-14.
REMARK 100 THE DEPOSITION ID IS D_1290059703.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 25-JUN-13
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : MAX II
REMARK 200 BEAMLINE : I911-3
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.91000
REMARK 200 MONOCHROMATOR : SI
REMARK 200 OPTICS : MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26209
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700
REMARK 200 RESOLUTION RANGE LOW (A) : 31.510
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 200 DATA REDUNDANCY : 3.600
REMARK 200 R MERGE (I) : 0.09000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8
REMARK 200 DATA REDUNDANCY IN SHELL : 3.60
REMARK 200 R MERGE FOR SHELL (I) : 0.31000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: REFMAC
REMARK 200 STARTING MODEL: NON-PUBLISHED
REMARK 200
REMARK 200 REMARK: NONE
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 54.23
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.08500
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.95000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.08500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.95000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5580 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9200 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -50.3 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O HOH B 2113 O HOH B 2117 1.51
REMARK 500 O HOH B 2011 O HOH B 2047 1.52
REMARK 500 O HOH A 2115 O HOH A 2116 1.58
REMARK 500 O THR B 180 O HOH B 2104 1.62
REMARK 500 O HOH A 2141 O HOH B 2025 1.66
REMARK 500 O HOH B 2015 O HOH B 2016 1.75
REMARK 500 O HOH A 2107 O HOH A 2109 1.75
REMARK 500 O HOH A 2130 O HOH A 2132 1.80
REMARK 500 OD1 ASN A 88 CL CL A 1100 1.80
REMARK 500 O HOH A 2136 O HOH A 2137 1.86
REMARK 500 CG2 THR A 4 O HOH A 2028 1.91
REMARK 500 O HOH A 2012 O HOH B 2110 1.94
REMARK 500 O HOH A 2024 O HOH A 2141 1.95
REMARK 500 O HOH A 2053 O HOH A 2076 1.99
REMARK 500 O HOH B 2018 O HOH B 2110 2.03
REMARK 500 O HOH A 2015 O HOH B 2110 2.05
REMARK 500 O HOH B 2086 O HOH B 2089 2.06
REMARK 500 O HOH A 2094 O HOH A 2095 2.10
REMARK 500 O HOH A 2005 O HOH A 2014 2.12
REMARK 500 O HOH B 2115 O HOH B 2117 2.13
REMARK 500 O HOH A 2008 O HOH A 2025 2.15
REMARK 500 O HOH A 2019 O HOH A 2026 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 O HOH A 2082 O HOH B 2098 4455 2.04
REMARK 500 NE2 GLN A 7 O HOH B 2104 4555 2.05
REMARK 500 O HOH A 2110 O HOH A 2110 2665 2.06
REMARK 500 O HOH A 2088 O HOH B 2100 4455 2.13
REMARK 500 O HOH A 2021 O HOH B 2006 4555 2.16
REMARK 500 O HOH A 2109 O HOH A 2117 2665 2.18
REMARK 500 O HOH A 2023 O HOH B 2029 2665 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A2111 DISTANCE = 5.93 ANGSTROMS
REMARK 525 HOH B2118 DISTANCE = 9.59 ANGSTROMS
REMARK 525 HOH B2120 DISTANCE = 9.66 ANGSTROMS
REMARK 525 HOH B2121 DISTANCE = 8.02 ANGSTROMS
REMARK 700
REMARK 700 SHEET
REMARK 700 DETERMINATION METHOD: DSSP
REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS
REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY
REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS
REMARK 700 ARE IDENTICAL.
REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS
REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY
REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS
REMARK 700 ARE IDENTICAL.
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 1200
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1100
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 1201
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1T8 B 1202
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4CPQ RELATED DB: PDB
REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS
REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL
REMARK 900 RELATED ID: 4CPR RELATED DB: PDB
REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS
REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL
REMARK 900 RELATED ID: 4CPS RELATED DB: PDB
REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS
REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL
REMARK 900 RELATED ID: 4CPU RELATED DB: PDB
REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS
REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL
REMARK 900 RELATED ID: 4CPW RELATED DB: PDB
REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS
REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL
REMARK 900 RELATED ID: 4CPX RELATED DB: PDB
REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS
REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL
DBREF 4CPT A 1 99 UNP P03366 POL_HV1B1 501 599
DBREF 4CPT B 101 199 UNP P03366 POL_HV1B1 501 599
SEQADV 4CPT PRO A 63 UNP P03366 LEU 563 ENGINEERED MUTATION
SEQADV 4CPT THR A 82 UNP P03366 VAL 582 ENGINEERED MUTATION
SEQADV 4CPT VAL A 84 UNP P03366 ILE 584 ENGINEERED MUTATION
SEQADV 4CPT PRO B 163 UNP P03366 LEU 563 ENGINEERED MUTATION
SEQADV 4CPT THR B 182 UNP P03366 VAL 582 ENGINEERED MUTATION
SEQADV 4CPT VAL B 184 UNP P03366 ILE 584 ENGINEERED MUTATION
SEQRES 1 A 99 PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE
SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 A 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO
SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU
SEQRES 6 A 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 A 99 PRO THR PRO THR ASN VAL ILE GLY ARG ASN LEU LEU THR
SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE
SEQRES 1 B 99 PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE
SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 B 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO
SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU
SEQRES 6 B 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 B 99 PRO THR PRO THR ASN VAL ILE GLY ARG ASN LEU LEU THR
SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE
HET CL A1100 1
HET CL B1200 1
HET CL B1201 1
HET 1T8 B1202 53
HETNAM CL CHLORIDE ION
HETNAM 1T8 METHYL [(2S)-1-(2-{3-[(3R,6S,10Z)-3-HYDROXY-4,7-DIOXO-
HETNAM 2 1T8 6-(PROPAN-2-YL)-5,8-DIAZABICYCLO[11.2.2]HEPTADECA-
HETNAM 3 1T8 1(15),10,13,16-TETRAEN-3-YL]PROPYL}-2-[4-(PYRIDIN-3-
HETNAM 4 1T8 YL)BENZYL]HYDRAZINYL)-3,3-DIMETHYL-1-OXOBUTAN-2-
HETNAM 5 1T8 YL]CARBAMATE
FORMUL 3 CL 3(CL 1-)
FORMUL 6 1T8 C41 H54 N6 O6
FORMUL 7 HOH *270(H2 O)
HELIX 1 1 GLY A 86 THR A 91 1 6
HELIX 2 2 GLY B 186 THR B 191 1 6
SHEET 1 AA 4 GLN A 2 ILE A 3 0
SHEET 2 AA 4 THR B 196 ASN B 198 -1 O LEU B 197 N ILE A 3
SHEET 3 AA 4 THR A 96 ASN A 98 -1 O THR A 96 N ASN B 198
SHEET 4 AA 4 GLN B 102 ILE B 103 -1 O ILE B 103 N LEU A 97
SHEET 1 AB 7 LEU A 10 ILE A 15 0
SHEET 2 AB 7 GLN A 18 LEU A 24 -1 O GLN A 18 N ILE A 15
SHEET 3 AB 7 VAL A 84 ILE A 85 1 N ILE A 85 O LEU A 23
SHEET 4 AB 7 VAL A 32 LEU A 33 -1 O VAL A 32 N VAL A 84
SHEET 5 AB 7 HIS A 69 VAL A 77 1 O LEU A 76 N LEU A 33
SHEET 6 AB 7 GLY A 52 ILE A 66 -1 O ARG A 57 N VAL A 77
SHEET 7 AB 7 LEU A 10 ILE A 15 0
SHEET 1 BA 7 LEU B 110 ILE B 115 0
SHEET 2 BA 7 GLN B 118 LEU B 124 -1 O GLN B 118 N ILE B 115
SHEET 3 BA 7 VAL B 184 ILE B 185 1 N ILE B 185 O LEU B 123
SHEET 4 BA 7 VAL B 132 LEU B 133 -1 O VAL B 132 N VAL B 184
SHEET 5 BA 7 HIS B 169 VAL B 177 1 O LEU B 176 N LEU B 133
SHEET 6 BA 7 GLY B 152 ILE B 166 -1 O ARG B 157 N VAL B 177
SHEET 7 BA 7 LEU B 110 ILE B 115 0
SITE 1 AC1 2 TRP B 106 HOH B2091
SITE 1 AC2 4 THR A 74 ASN A 88 HOH A2127 ARG B 141
SITE 1 AC3 3 THR B 174 ASN B 188 HOH B2106
SITE 1 AC4 20 ARG A 8 ASP A 25 GLY A 27 ALA A 28
SITE 2 AC4 20 ASP A 29 GLY A 48 GLY A 49 PRO A 81
SITE 3 AC4 20 THR A 82 HOH A2092 ARG B 108 LEU B 123
SITE 4 AC4 20 ASP B 125 GLY B 127 ALA B 128 ASP B 129
SITE 5 AC4 20 GLY B 148 GLY B 149 PHE B 153 HOH B2084
CRYST1 58.170 85.900 46.360 90.00 90.00 90.00 P 21 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017191 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011641 0.000000 0.00000
SCALE3 0.000000 0.000000 0.021570 0.00000